Update on depression and age-related macular degeneration

被引：82
作者：
Casten, Robin J. [1 ]
Rovner, Barry W. [2 ,3 ]
机构：
[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Psychiat & Human Behav, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Jefferson Med Coll, Dept Neurol, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Jefferson Med Coll, Dept Psychiat, Philadelphia, PA 19107 USA
来源：
CURRENT OPINION IN OPHTHALMOLOGY | 2013年 / 24卷 / 03期
关键词：
age-related macular degeneration; depression; late-onset vision loss; QUALITY-OF-LIFE; SELF-MANAGEMENT; VISION; SYMPTOMS; RANIBIZUMAB; PREVALENCE; ANXIETY; PEOPLE; ADULTS;
D O I：
10.1097/ICU.0b013e32835f8e55
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Purpose of review This review updates the literature on depression in age-related macular degeneration (AMD). Treatment for AMD has been revolutionized since the 2004 review of depression and AMD. New data describing the prevalence of depression in AMD, as well as novel interventions for managing depression in AMD, are discussed. Recent findings Depression continues to be prevalent in AMD and new information is available on the pathways by which impaired vision leads to depression. Strategies for the treatment of depression in patients with impaired vision have evolved. Summary AMD is still a major risk factor for depression and people with activity restriction due to vision loss are at greatest risk. An integrated approach to depression management in older adults with impaired vision may be the best course of action.
引用
收藏
页码：239 / 243
页数：5
相关论文
共 36 条
[1]  
American Academy of Ophthalmology Retina/Vitreous Panel, 2008, AGE REL MAC DEG
[2]   Anxiety and depression prevalence rates in age-related macular degeneration [J].
Augustin, Albert ;
Sahel, Jose-Alain ;
Bandello, Francesco ;
Dardennes, Roland ;
Maurel, Frederique ;
Negrini, Cristina ;
Hieke, Klaus ;
Berdeaux, Gilles .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2007, 48 (04) :1498-1503
[3]   Poor Vision, Functioning, and Depressive Symptoms: A Test of the Activity Restriction Model [J].
Bookwala, Jamila ;
Lawson, Brendan .
GERONTOLOGIST, 2011, 51 (06) :798-808
[4]   Self-management of age-related macular degeneration and quality of life - A randomized controlled trial [J].
Brody, BL ;
Roch-Levecq, AC ;
Gamst, AC ;
Maclean, K ;
Kaplan, RM ;
Brown, SI .
ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (11) :1477-1483
[5]   Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration [J].
Brody, BL ;
Gamst, AC ;
Williams, RA ;
Smith, AR ;
Lau, PW ;
Dolnak, D ;
Rapaport, MH ;
Kaplan, RM ;
Brown, SI .
OPHTHALMOLOGY, 2001, 108 (10) :1893-1900
[6]   Ranibizumab versus verteporfin for neovascular age-related macular degeneration [J].
Brown, David M. ;
Kaiser, Peter K. ;
Michels, Mark ;
Soubrane, Gisele ;
Heier, Jeffrey S. ;
Kim, Robert Y. ;
Sy, Judy P. ;
Schneider, Susan .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1432-1444
[7]   Let us wake the nation on the treatment for age-related macular degeneration [J].
Brown, Gary ;
Brown, Melissa M. .
CURRENT OPINION IN OPHTHALMOLOGY, 2010, 21 (03) :169-171
[8]   Depression Despite Anti-Vascular Endothelial Growth Factor Treatment of Age-Related Macular Degeneration [J].
Casten, Robin ;
Rovner, Barry W. ;
Leiby, Benjamin E. ;
Tasman, William .
ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (04) :506-508
[9]  
Casten Robin J, 2004, Curr Opin Ophthalmol, V15, P181, DOI 10.1097/01.icu.0000120710.35941.3f
[10]   Improved vision-related function after ranibizumab treatment of Neovascular age-related macular degeneration - Results of a randomized clinical trial [J].
Chang, Tom S. ;
Bressler, Neil M. ;
Fine, Jennifer T. ;
Dolan, Chantal W. ;
Ward, James ;
Klesert, Todd R. .
ARCHIVES OF OPHTHALMOLOGY, 2007, 125 (11) :1460-1469
1234